<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>44(9)</volume><submitter>Christoph M</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Uninterrupted direct oral anticoagulation (DOAC) in AF-ablation is recommended, proven by randomized trials. The outcome and the periinterventional differences between DOACs and VKA in the real world clinical practice are discussed controversial.&lt;h4>Hypothesis&lt;/h4>To investigate efficiency and safety of uninterrupted DOAC therapy compared to VKA during AF-Ablation in real world setting with a focus on periinterventional heparin dosage.</pubmed_abstract><journal>Clinical cardiology</journal><pagination>1243-1248</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8428011</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Comparison of uninterrupted direct oral anticoagulation with vitamin-K antagonists during AF-ablation in the clinical routine. A single center register.</pubmed_title><pmcid>PMC8428011</pmcid><pubmed_authors>Christoph M</pubmed_authors><pubmed_authors>Quick S</pubmed_authors><pubmed_authors>Youssef A</pubmed_authors><pubmed_authors>Huo Y</pubmed_authors><pubmed_authors>Francke A</pubmed_authors><pubmed_authors>Gaspar T</pubmed_authors><pubmed_authors>Svitil J</pubmed_authors><pubmed_authors>Wunderlich C</pubmed_authors><pubmed_authors>Schoen S</pubmed_authors><pubmed_authors>Forkmann M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Comparison of uninterrupted direct oral anticoagulation with vitamin-K antagonists during AF-ablation in the clinical routine. A single center register.</name><description>&lt;h4>Background&lt;/h4>Uninterrupted direct oral anticoagulation (DOAC) in AF-ablation is recommended, proven by randomized trials. The outcome and the periinterventional differences between DOACs and VKA in the real world clinical practice are discussed controversial.&lt;h4>Hypothesis&lt;/h4>To investigate efficiency and safety of uninterrupted DOAC therapy compared to VKA during AF-Ablation in real world setting with a focus on periinterventional heparin dosage.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep</publication><modification>2025-04-19T10:09:24.951Z</modification><creation>2022-02-11T10:35:31.514Z</creation></dates><accession>S-EPMC8428011</accession><cross_references><pubmed>34312888</pubmed><doi>10.1002/clc.23676</doi></cross_references></HashMap>